1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

HIV drug creator Antonin Holy dies at 75

By source, Jul 17, 2012 | |
  1. source
    (Reuters) - Czech scientist Antonin Holy, who played an important role in creating drugs to treat HIV and AIDS, has died at the age of 75, the Czech Academy of Sciences said on Tuesday.

    Holy, who won a number of prestigious awards including the European Union's Descartes Prize for science in 2001, also helped develop the drug Vestide, used for the treatment of retinitis in AIDS patients, and Hepsera to treat hepatitis B. He died after battling an unspecified long-term disease.

    Holy died on Monday - the day U.S. health regulators for the first time approved using Truvada, a drug that he helped develop, to prevent infection in people who face a high risk of contracting the virus that causes AIDS.

    "It is a huge loss," said Zdenek Havlas, a former chief of the Institute of Organic Chemistry and Biochemistry at the Czech Academy of Sciences, who worked there with Holy for 35 years. "He belonged and he always will belong among the greatest chemists and scientists."

    "He had a special talent for looking at a chemical structure to tell immediately whether it was worth continuing to explore and whether it would have any effects."

    Under communist rule in the former Czechoslovakia, Holy was banned from supervising students and worked alone with the help of just one technician.

    After the fall of the communist regime in 1989, he was allowed to build his team and began to give lectures at Czech universities. In 2008 he received an honorary professorship at the University of Manchester's School of Chemistry in Britain.
    U.S. pharmaceutical company Gilead Sciences Inc, the makers of Truvada, donated millions of dollars to the Institute of Organic Chemistry and Biochemistry, and part of that donation was used to fund his research.

    (Reporting by Jana Mlcochova; Editing by Chris Wickham and Pravin Char)

    Article found here on uk.reuters.com


To make a comment simply sign up and become a member!